Home  >  Products  >  DGAT2L4 (diacylglycerol O-acyltransferase 2-like 4) Blocking Peptide (the C terminal of protein) (100ug)
DGAT2L4 (diacylglycerol O-acyltransferase 2-like 4) Blocking Peptide (the C terminal of protein) (100ug)

DGAT2L4 (diacylglycerol O-acyltransferase 2-like 4) Blocking Peptide (the C terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DGAT2L4 antibody (Catalogue #: ARP44425_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP44425
Size: 100 ug
Weight: 38kDa
Gene: 158835
Format: Lyophilized powder
Target: DGAT2L4 is acyltransferase that predominantly esterify long chain (wax) alcohols with acyl-CoA-derived fatty acids to produce wax esters. Wax esters are enriched in sebum, suggesting that it plays a central role in lipid metabolism in skin. It has no activity using decyl alcohol and significantly prefers the C16 and C18 alcohols. DGAT2L4 may also have 2-acylglycerol O-acyltransferase (MGAT) and acyl-CoA:retinol acyltransferase (ARAT) activities, to catalyze the synthesis of diacylglycerols and retinyl esters, however this activity is unclear in vivo.
Alternative names: AWAT2; DC4; MFAT